Logo do repositório
 
Publicação

Determining treatment pathways for older patients with acute myeloid leukemia: patient and clinician perspectives

2025-01-01Artigo de investigação Acesso aberto
Ver registo simples
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorOliva, Esther N.
dc.contributor.authorAlmeida, António
dc.date.accessioned2025-09-05T08:04:08Z
dc.date.available2025-09-05T08:04:08Z
dc.date.issued2025-01-01
dc.description.abstractIntroduction: Achieving remission and prolonging duration of response are the primary treatment objectives for patients with acute myeloid leukemia (AML). However, identifying the best approach for older patients poses a significant challenge. This review explores the treatment pathways for older patients, especially those not eligible for stem cell transplantation and emphasizes the importance of optimizing outcomes by actively involving patients in their care plans. Areas covered: There is currently no clinical consensus on when to use intensive or less-intensive induction chemotherapy for older patients, and more empirical evidence is needed. Meanwhile, this decision must still account for patients’ preferences and circumstances in addition to the benefits and risks of therapy. Survey data have shown that patients want to be involved in their treatment decisions and that higher patient engagement improves patient-reported quality of care and satisfaction. While the importance of patient engagement is widely recognized, clinicians can work toward bridging the gap between patients’ preferred and perceived levels of involvement in their treatment decisions. Expert opinion: Patient engagement in treatment decisions is particularly important for older patients with AML. Understanding patients’ perspectives and expectations for clinical and quality-of-life outcomes is essential to tailoring the most appropriate and effective treatment plan.eng
dc.identifier.citationOliva, E. N., & Almeida, A. (2025). Determining treatment pathways for older patients with acute myeloid leukemia: patient and clinician perspectives. Expert Review of Hematology, 18(8), 595-604. https://doi.org/10.1080/17474086.2025.2521397
dc.identifier.doi10.1080/17474086.2025.2521397
dc.identifier.eid105008981030
dc.identifier.issn1747-4086
dc.identifier.othereceb9403-52cb-427c-9373-51d3b58ada66
dc.identifier.pmid40525509
dc.identifier.urihttp://hdl.handle.net/10400.14/54668
dc.identifier.wos001513428600001
dc.language.isoeng
dc.peerreviewedyes
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAcute myeloid leukemia
dc.subjectintensive chemotherapy
dc.subjectPatient-centered care
dc.subjectQuality of life
dc.subjectShared decision-making
dc.subjectTreatment
dc.titleDetermining treatment pathways for older patients with acute myeloid leukemia: patient and clinician perspectiveseng
dc.typeresearch article
dspace.entity.typePublication
oaire.citation.endPage604
oaire.citation.issue8
oaire.citation.startPage595
oaire.citation.titleExpert Review of Hematology
oaire.citation.volume18
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
123045321.pdf
Tamanho:
2.37 MB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

CIIS - Contribuições em Revistas Científicas / Contribution to Journals